Yersinia Diagnostics Market

Table of Content

1. Executive Summary

    1.1. Global Yersinia Diagnostics Market Snapshot, 2024 and 2031

    1.2. Market Opportunity Assessment, 2024 – 2031, US$ Mn

    1.3. Key Market Trends

    1.4. Future Market Projections

    1.5. Premium Market Insights

    1.6. Industry Developments and Key Market Events 

    1.7. PMR Analysis and Recommendations

2. Market Overview

    2.1. Market Scope and Definition

    2.2. Market Dynamics

        2.2.1. Drivers

        2.2.2. Restraints

        2.2.3. Opportunity

        2.2.4. Key Trends

    2.3. Macro-Economic Factors

        2.3.1. Global Sectorial Outlook

        2.3.2. Global GDP Growth Outlook

        2.3.3. Global Healthcare Spending Outlook

    2.4. COVID-19 Impact Analysis

    2.5. Forecast Factors – Relevance and Impact

3. Value Added Insights 

    3.1. Product Adoption Analysis

    3.2. Disease Epidemiology

    3.3. Technology Assessment

    3.4. Regulatory Landscape

    3.5. Supply Chain Analysis

    3.6. Key Deals and Mergers

    3.7. PESTLE Analysis

    3.8. Porter’s Five Force Analysis 

4. Global Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)

    4.1. Key Highlights

        4.1.1. Market Size (US$ Mn) and Y-o-Y Growth

        4.1.2. Absolute $ Opportunity

    4.2. Market Size (US$ Mn) Analysis and Forecast

        4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022

        4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023–2031

    4.3. Global Yersinia Diagnostics Market Outlook: Product

        4.3.1. Introduction / Key Findings

        4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2018 – 2022

        4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031

            4.3.3.1. Instruments 

            4.3.3.2. Kits and Reagents

    4.4. Market Attractiveness Analysis: Product

    4.5. Global Yersinia Diagnostics Market Outlook: Diagnostic Test

        4.5.1. Introduction / Key Findings

        4.5.2. Historical Market Size (US$ Mn) Analysis, By Diagnostic Test, 2018 – 2022

        4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031

            4.5.3.1. Stool Culture

            4.5.3.2. Imaging Tests

            4.5.3.3. Serological Tests

            4.5.3.4. Colonoscopy

            4.5.3.5. Others

    4.6. Market Attractiveness Analysis: Diagnostic Test

    4.7. Global Yersinia Diagnostics Market Outlook: Technology

        4.7.1. Introduction / Key Findings

        4.7.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2018 – 2022

        4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031

            4.7.3.1. Immunoassay

            4.7.3.2. DNA Probes

            4.7.3.3. Polymerase Chain Reaction (PCR)

            4.7.3.4. Flow Cytometry

            4.7.3.5. Chromatography

            4.7.3.6. Others

    4.8. Market Attractiveness Analysis: Technology

    4.9. Global Yersinia Diagnostics Market Outlook: End User

        4.9.1. Introduction / Key Findings

        4.9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2018 – 2022

        4.9.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031

            4.9.3.1. Hospitals

            4.9.3.2. Public Health Laboratories

            4.9.3.3. Commercial Laboratories

            4.9.3.4. Others

    4.10. Market Attractiveness Analysis: End User

5. Global Yersinia Diagnostics Market Outlook: Region

    5.1. Key Highlights

    5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 – 2022

    5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 – 2031

        5.3.1. North America

        5.3.2. Europe

        5.3.3. East Asia

        5.3.4. South Asia and Oceania

        5.3.5. Latin America

        5.3.6. Middle East & Africa

    5.4. Market Attractiveness Analysis: Region

6. North America Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031) 

    6.1. Key Highlights

    6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022

        6.2.1. By Country

        6.2.2. By Product

        6.2.3. By Diagnostic Test

        6.2.4. By Technology

        6.2.5. By End User

    6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031

        6.3.1. U.S.

        6.3.2. Canada

    6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031

        6.4.1. Instruments 

        6.4.2. Kits and Reagents

    6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031

        6.5.1. Stool Culture

        6.5.2. Imaging Tests

        6.5.3. Serological Tests

        6.5.4. Colonoscopy

        6.5.5. Others

    6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031

        6.6.1. Immunoassay

        6.6.2. DNA Probes

        6.6.3. Polymerase Chain Reaction (PCR)

        6.6.4. Flow Cytometry

        6.6.5. Chromatography

        6.6.6. Others

    6.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031

        6.7.1. Hospitals

        6.7.2. Public Health Laboratories

        6.7.3. Commercial Laboratories

        6.7.4. Others

    6.8. Market Attractiveness Analysis

7. Europe Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)

    7.1. Key Highlights

    7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022

        7.2.1. By Country

        7.2.2. By Product

        7.2.3. By Diagnostic Test

        7.2.4. By Technology

        7.2.5. By End User

    7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031

        7.3.1. Germany

        7.3.2. France

        7.3.3. U.K.

        7.3.4. Italy

        7.3.5. Spain

        7.3.6. Russia

        7.3.7. Türkiye

        7.3.8. Rest of Europe

    7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031

        7.4.1. Instruments 

        7.4.2. Kits and Reagents

    7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031

        7.5.1. Stool Culture

        7.5.2. Imaging Tests

        7.5.3. Serological Tests

        7.5.4. Colonoscopy

        7.5.5. Others

    7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031

        7.6.1. Immunoassay

        7.6.2. DNA Probes

        7.6.3. Polymerase Chain Reaction (PCR)

        7.6.4. Flow Cytometry

        7.6.5. Chromatography

        7.6.6. Others

    7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031

        7.7.1. Hospitals

        7.7.2. Public Health Laboratories

        7.7.3. Commercial Laboratories

        7.7.4. Others

    7.8. Market Attractiveness Analysis

8. East Asia Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)

    8.1. Key Highlights

    8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022

        8.2.1. By Country

        8.2.2. By Product

        8.2.3. By Diagnostic Test

        8.2.4. By Technology

        8.2.5. By End User

    8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031

        8.3.1. China

        8.3.2. Japan

        8.3.3. South Korea

    8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031

        8.4.1. Instruments 

        8.4.2. Kits and Reagents

    8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031

        8.5.1. Stool Culture

        8.5.2. Imaging Tests

        8.5.3. Serological Tests

        8.5.4. Colonoscopy

        8.5.5. Others

    8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031

        8.6.1. Immunoassay

        8.6.2. DNA Probes

        8.6.3. Polymerase Chain Reaction (PCR)

        8.6.4. Flow Cytometry

        8.6.5. Chromatography

        8.6.6. Others

    8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031

        8.7.1. Hospitals

        8.7.2. Public Health Laboratories

        8.7.3. Commercial Laboratories

        8.7.4. Others

    8.8. Market Attractiveness Analysis

9. South Asia & Oceania Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)

    9.1. Key Highlights

    9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022

        9.2.1. By Country

        9.2.2. By Product

        9.2.3. By Diagnostic Test

        9.2.4. By Technology

        9.2.5. By End User

    9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031

        9.3.1. India

        9.3.2. Southeast Asia

        9.3.3. ANZ

        9.3.4. Rest of South Asia & Oceania

    9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031

        9.4.1. Instruments 

        9.4.2. Kits and Reagents

    9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031

        9.5.1. Stool Culture

        9.5.2. Imaging Tests

        9.5.3. Serological Tests

        9.5.4. Colonoscopy

        9.5.5. Others

    9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031

        9.6.1. Immunoassay

        9.6.2. DNA Probes

        9.6.3. Polymerase Chain Reaction (PCR)

        9.6.4. Flow Cytometry

        9.6.5. Chromatography

        9.6.6. Others

    9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031

        9.7.1. Hospitals

        9.7.2. Public Health Laboratories

        9.7.3. Commercial Laboratories

        9.7.4. Others

    9.8. Market Attractiveness Analysis

10. Latin America Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)

    10.1. Key Highlights

    10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022

        10.2.1. By Country

        10.2.2. By Product

        10.2.3. By Diagnostic Test

        10.2.4. By Technology

        10.2.5. By End User

    10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031

        10.3.1. Brazil

        10.3.2. Mexico

        10.3.3. Rest of Latin America

    10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031

        10.4.1. Instruments 

        10.4.2. Kits and Reagents

    10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031

        10.5.1. Stool Culture

        10.5.2. Imaging Tests

        10.5.3. Serological Tests

        10.5.4. Colonoscopy

        10.5.5. Others

    10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031

        10.6.1. Immunoassay

        10.6.2. DNA Probes

        10.6.3. Polymerase Chain Reaction (PCR)

        10.6.4. Flow Cytometry

        10.6.5. Chromatography

        10.6.6. Others

    10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031

        10.7.1. Hospitals

        10.7.2. Public Health Laboratories

        10.7.3. Commercial Laboratories

        10.7.4. Others

    10.8. Market Attractiveness Analysis

11. Middle East & Africa Yersinia Diagnostics Market Outlook: Historical (2018 – 2023) and Forecast (2024 – 2031)

    11.1. Key Highlights

    11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 – 2022

        11.2.1. By Country

        11.2.2. By Product

        11.2.3. By Diagnostic Test

        11.2.4. By Technology

        11.2.5. By End User

    11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 – 2031

        11.3.1. GCC Countries

        11.3.2. Egypt

        11.3.3. South Africa

        11.3.4. Northern Africa

        11.3.5. Rest of Middle East & Africa

    11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2023 – 2031

        11.4.1. Instruments 

        11.4.2. Kits and Reagents

    11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2023 – 2031

        11.5.1. Stool Culture

        11.5.2. Imaging Tests

        11.5.3. Serological Tests

        11.5.4. Colonoscopy

        11.5.5. Others

    11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2023 – 2031

        11.6.1. Immunoassay

        11.6.2. DNA Probes

        11.6.3. Polymerase Chain Reaction (PCR)

        11.6.4. Flow Cytometry

        11.6.5. Chromatography

        11.6.6. Others

    11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 – 2031

        11.7.1. Hospitals

        11.7.2. Public Health Laboratories

        11.7.3. Commercial Laboratories

        11.7.4. Others

    11.8. Market Attractiveness Analysis

12. Competition Landscape

    12.1. Market Share Analysis, 2023

    12.2. Market Structure

        12.2.1. Competition Intensity Mapping By Market 

        12.2.2. Competition Dashboard

    12.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

        12.3.1. TestLine Clinical Diagnostics s.r.o

            12.3.1.1. Overview

            12.3.1.2. Segments and Products

            12.3.1.3. Key Financials

            12.3.1.4. Market Developments

            12.3.1.5. Market Strategy

        12.3.2. CERTEST BIOTEC

            12.3.2.1. Overview

            12.3.2.2. Segments and Products

            12.3.2.3. Key Financials

            12.3.2.4. Market Developments

            12.3.2.5. Market Strategy

        12.3.3. T2 Biosystems

            12.3.3.1. Overview

            12.3.3.2. Segments and Products

            12.3.3.3. Key Financials

            12.3.3.4. Market Developments

            12.3.3.5. Market Strategy

        12.3.4. Demeditec Diagnostics GmbH

            12.3.4.1. Overview

            12.3.4.2. Segments and Products

            12.3.4.3. Key Financials

            12.3.4.4. Market Developments

            12.3.4.5. Market Strategy

        12.3.5. Launch Diagnostics Limited

            12.3.5.1. Overview

            12.3.5.2. Segments and Products

            12.3.5.3. Key Financials

            12.3.5.4. Market Developments

            12.3.5.5. Market Strategy

        12.3.6. ELITech Group

            12.3.6.1. Overview

            12.3.6.2. Segments and Products

            12.3.6.3. Key Financials

            12.3.6.4. Market Developments

            12.3.6.5. Market Strategy

        12.3.7. Advanced Molecular Diagnostics

            12.3.7.1. Overview

            12.3.7.2. Segments and Products

            12.3.7.3. Key Financials

            12.3.7.4. Market Developments

            12.3.7.5. Market Strategy

        12.3.8. SeraCare (LGC Clinical Diagnostics)

            12.3.8.1. Overview

            12.3.8.2. Segments and Products

            12.3.8.3. Key Financials

            12.3.8.4. Market Developments

            12.3.8.5. Market Strategy

        12.3.9. Hygiena LLC

            12.3.9.1. Overview

            12.3.9.2. Segments and Products

            12.3.9.3. Key Financials

            12.3.9.4. Market Developments

            12.3.9.5. Market Strategy

        12.3.10. Diagnostiki Athinon

            12.3.10.1. Overview

            12.3.10.2. Segments and Products

            12.3.10.3. Key Financials

            12.3.10.4. Market Developments

            12.3.10.5. Market Strategy

        12.3.11. QED Bioscience Inc.

            12.3.11.1. Overview

            12.3.11.2. Segments and Products

            12.3.11.3. Key Financials

            12.3.11.4. Market Developments

            12.3.11.5. Market Strategy

        12.3.12. BioFire Defense

            12.3.12.1. Overview

            12.3.12.2. Segments and Products

            12.3.12.3. Key Financials

            12.3.12.4. Market Developments

            12.3.12.5. Market Strategy

        12.3.13. VIROTECH Diagnostics GmbH

            12.3.13.1. Overview

            12.3.13.2. Segments and Products

            12.3.13.3. Key Financials

            12.3.13.4. Market Developments

            12.3.13.5. Market Strategy

        12.3.14. Thermo Fisher Scientific Inc.

            12.3.14.1. Overview

            12.3.14.2. Segments and Products

            12.3.14.3. Key Financials

            12.3.14.4. Market Developments

            12.3.14.5. Market Strategy

        12.3.15. Seegene Inc. 

            12.3.15.1. Overview

            12.3.15.2. Segments and Products

            12.3.15.3. Key Financials

            12.3.15.4. Market Developments

            12.3.15.5. Market Strategy

        12.3.16. Diasorin S.p.A.

            12.3.16.1. Overview

            12.3.16.2. Segments and Products

            12.3.16.3. Key Financials

            12.3.16.4. Market Developments

            12.3.16.5. Market Strategy

13. Appendix

    13.1. Research Methodology

    13.2. Research Assumptions

    13.3. Acronyms and Abbreviations

List Of Table

- List Of Chart -